Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

AMD Says Delayed 7040HS 'Phoenix' Laptop CPUs Are Now Shipping to OEMs

AMD says that it has made its own self-imposed deadline to ship its Ryzen 7040HS laptop processors, also known as the "Phoenix" series, to OEMs.

Tom’s Hardware

High Court hearing to begin over hormone pregnancy test blamed for birth defects

More than 200 people are launching a legal case after claiming to be caused harm by the drug Primodos, which was given to women to test if they were pregnant from the 1950s until the late 1970s

Wales Online

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune

From analysis to the latest developments in health,
read the most diverse news in one place.

Recruitment of drug inspectors: Karnataka HC directs govt to redo selection list

BENGALURU: Finding fault with the authorities with regards to insertion of “18 months experience clause” at a belated stage in the eligibility criteria pertaining to selection of Drug Inspectors, the Karnataka high court has quashed the entire selection list published in November 2020.

The Times of India

Frustration grows over wait on OxyContin maker's settlement

More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet

The Independent UK

Healthy Returns: This A Rated Healthcare Stock Is a Must-Watch for May

Given the pharmaceutical industry’s robust growth prospects, drug-maker Neurocrine Biosciences’ (NBIX) stock is worth watching ahead of its first-quarter earnings next week. Read on….

StockNews.com

Vermont passes bills aimed at protecting abortion pills

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

A Prescription for Success: Check Out This Strong Pharmaceutical Stock This Week

Leading biotech company Regeneron Pharmaceuticals (REGN) has exhibited robust financial growth in recent years. With the biotech industry’s promising prospects, this stock might be a solid portfolio addition now. Read on….

StockNews.com

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The Guardian - UK

Shield Therapeutics hails US market progress and mulls stateside listing

The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand

Birmingham Post

The long and winding history of the war on abortion drugs

Along with the stethoscope and camembert cheese, mifepristone may be one of France’s greatest inventions. It’s one of two drugs taken for medical abortions, along with misoprostol, and has been making headlines in the US, where a Texas judge issued a ruling to ban it nationwide. FRANCE 24 takes a…

France 24

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

The Guardian - UK

Smith & Nephew reports strong first quarter growth with £44m sales uplift

Hull-founded firm enjoying double digit expansion in largest established market as it awaits consent for East Yorkshire build

Birmingham Post

Regional pharmacists say 60-day medication changes could 'break' overwhelmed system

The extension of dispensing timelines on hundreds of medications will lead to pharmacies closing and impact healthcare access, according to pharmacists in regional NSW.

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Drug for rare form of Lou Gehrig’s disease OK'd by FDA

U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease

Radio France Internationale

WHO warns of 'extreme biohazard risk' as fighters occupy Sudan's national laboratory

The World Health Organization says that fighters in Sudan have occupied the national public laboratory holding samples of diseases including polio and measles, creating an "extremely, extremely dangerous" situation.

Birmingham Post

King's Award for export success through Covid for pharma packaging firm launched in Grimsby

ALLpaQ recognised for outstanding international trade after role in US vaccine roll-out

The Guardian - UK

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Canada will try to offer abortion drug mifepristone to American women if it’s banned in the US

Canada’s Families Minister Karina Gould reacted to the US legal battle over mifepristone the day before the US Supreme Court ruling

Tribune News Service

US Supreme Court keeps abortion pill fully available for now

WASHINGTON — The U.S. Supreme Court blocked a Texas judge’s restrictions on a widely used abortion pill from taking effect, keeping the drug fully available while a legal fight goes forward.

The Guardian - US

US supreme court blocks ruling limiting access to abortion pill

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

StockNews.com

2 Healthcare Stocks Showing Stability With A and B POWR Ratings

The healthcare industry should thrive with accelerated breakthrough developments and a growing market for telemedicine and personalized medicines. Moreover, given the lingering macroeconomic headwinds, fundamentally strong healthcare stocks, Amgen (AMGN), and Otsuka Holdings (OTSKY) showing Stability with A and B POWR Ratings could be ideal buys. Read more.

StockNews.com

Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals (SNDX), Senseonics Holdings (SENS), and Sio Gene Therapies (SIOX) due to their bleak fundamentals. Keep reading….

StockNews.com

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

Tribune News Service

Supreme Court delays decision in abortion drug case

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

1 … 55 56 57 58

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

World Health Organization

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.